600285.SH
羚锐制药
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 19.58
+0.20%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
11.1x
Market Cap
CNY 11.10B
MomentumView details →
1D Return
+0.20%
YTD Return
−5.31%
RSI (14)
37.0
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
11.1x
Market Cap
CNY 11.10B
RSI (14)
37.0
MomentumView details →
1D Return
+0.20%
YTD Return
−5.31%
Similar companies
Latest newsMore news →
As of August 20, 2026, more than 30 A-share listed companies disclosed securities firms among their top ten circulating shareholders in their 2026 semi-annual reports, with some firms increasing stakes and others newly appearing.15d agoLingrui Pharmaceutical disclosed its semi-annual report on August 11, reporting revenue of 2.148 billion yuan, up 2.32% year-on-year, and net profit attributable to shareholders of 495 million yuan, up 4.36% year-on-year.25d ago